The role of NF-kB mediation of cellular adhesion processes is also of interest in the context of cancer immunotherapy [139], although the mechanism by which pathological NF-kB activation occurs in malignant disease remains a subject of ongoing debate. Here, NFKB1 is linked to cancer.